Personalizing potassium management in patients on haemodialysis
- PMID: 33089313
- PMCID: PMC7771972
- DOI: 10.1093/ndt/gfaa213
Personalizing potassium management in patients on haemodialysis
Figures
Comment on
-
Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis-the French Renal Epidemiology and Information Network registry.Nephrol Dial Transplant. 2021 Jan 1;36(1):151-159. doi: 10.1093/ndt/gfaa077. Nephrol Dial Transplant. 2021. PMID: 32582941
References
-
- Sandle GI, Gaiger E, Tapster S. et al. Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis. Clin Sci (Lond) 1987; 73: 247–252 - PubMed
-
- Rossignol P, Lamiral Z, Frimat L. et al. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey. Nephrol Dial Transplant 2017; 32: 2112–2118 - PubMed
-
- Kovesdy CP, Regidor DL, Mehrotra R. et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2007; 2: 999–1007 - PubMed
-
- Brunelli SM, Du Mond C, Oestreicher N. et al. Serum potassium and short-term clinical outcomes among hemodialysis patients: impact of the long interdialytic interval. Am J Kidney Dis 2017; 70: 21–29 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
